Mirae Asset Global Investments Co., Ltd. Agenus Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$1.12 - $1.88 $5,463 - $9,170	4,878 Added 9.92%	54,059 $61,000
Q2 2023 Aug 10, 2023	SELL	$1.31 - $2.04 $43,844 - $68,276	-33,469 Reduced 40.49%	49,181 $78,000
Q1 2023 May 04, 2023	BUY	$1.45 - $2.95 $119,842 - $243,817	82,650 New	82,650 $125,000
Q1 2022 May 10, 2022	SELL	$2.35 - $3.47 $25,257 - $37,295	-10,748 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$2.92 - $5.74 $31,384 - $61,693	10,748 New	10,748 $35,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.